B. Kiberd

发表

Cumulative risk for developing end-stage renal disease in the US population.

B. Kiberd, C. Clase, 2002, Journal of the American Society of Nephrology : JASN.

Prevalence of Frailty in Patients Referred to the Kidney Transplant Waitlist

N. Tangri, K. Rockwood, B. Kiberd, 2021, Kidney360.

The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation.

M. Tonelli, B. Kiberd, B. Pereira, 2005, Kidney international.

Metabolic acidosis in hemodialysis patients: a study of prevalence and factors affecting intradialytic bicarbonate gain.

B. Kiberd, K. Jindal, F. Sepandj, 1996, Artificial organs.

Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney Transplantation

B. Kiberd, T. Keough-Ryan, P. Belitsky, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The impact of an “acute dialysis start” on the mortality attributed to the use of central venous catheters: a retrospective cohort study

S. Soroka, B. Kiberd, K. Tennankore, 2012, BMC Nephrology.

Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.

J. Cox, B. Kiberd, C. Clase, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The marginal cost of satellite versus in‐center hemodialysis

S. Soroka, B. Kiberd, P. Jacobs, 2005, Hemodialysis international. International Symposium on Home Hemodialysis.

The impact of vascular anastomosis time on early kidney transplant outcomes

B. Kiberd, K. Marzouk, Bryce A Kiberd, 2013, Transplantation research.

Factors Associated With Prolonged Warm Ischemia Time Among Deceased Donor Kidney Transplant Recipients

B. Kiberd, A. Vinson, K. Tennankore, 2018, Transplantation direct.

with graft failure and mortality after kidney Prolonged warm ischemia time is associated transplantation

B. Kiberd, K. Tennankore, S. Kim, 2016 .

Correlation of Surgical Times with Laparoscopic Live Donor Kidney Transplant Outcomes

B. Kiberd, I. Alwayn, J. Lawen, 2013 .

Relationship between Glomerular Filtration Rate and the Prevalence of Metabolic Abnormalities: Results from the Third National Health and Nutrition Examination Survey (NHANES III)

A. Garg, B. Kiberd, C. Clase, 2007, Nephron Clinical Practice.

Guidelines for the treatment and management of new‐onset diabetes after transplantation 1

M. Schnitzler, P. Marchetti, P. Home, 2005, Clinical transplantation.

RISK FACTORS ASSOCIATED WITH KIDNEY DISEASE OR TRANSPLANTATION Kidney disease and kidney transplantation

B. Kiberd, 2007 .

Atorvastatin has no beneficial effect on cardiovascular outcomes in patients with advanced chronic kidney disease

B. Kiberd, 2006, Nature Clinical Practice Nephrology.

Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III).

A. Garg, B. Kiberd, C. Clase, 2002, Journal of the American Society of Nephrology : JASN.

In Search of a Better Outcome: Opting Into the Live Donor Paired Kidney Exchange Program

B. Kiberd, A. Vinson, K. Tennankore, 2021, Canadian journal of kidney health and disease.

Death, taxes, and now CKD.

B. Kiberd, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Estimating the long term impact of kidney donation on life expectancy and end stage renal disease

B. Kiberd, 2013, Transplantation research.

The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design.

D. Holland, G. Knoll, B. Kiberd, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cancer Mortality in Kidney Transplantation

B. Kiberd, J. Gill, J. Gill, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Referral for Kidney Transplantation in Canadian Provinces.

G. Knoll, B. Kiberd, S. Kim, 2019, Journal of the American Society of Nephrology : JASN.

Screening for chronic kidney disease

B. Kiberd, 2010, BMJ : British Medical Journal.

Development of end stage renal disease following an acute cardiac event.

J. Cox, B. Kiberd, C. Clase, 2008, Kidney international.

Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk

B. Kiberd, K. West, K. Tennankore, 2014, Transplantation research.

Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.

D. Holland, G. Knoll, B. Kiberd, 2016, The lancet. Diabetes & endocrinology.

Screening to Prevent Polyoma Virus Nephropathy in Kidney Transplantation: A Cost Analysis

B. Kiberd, R. Panek, F. Smith, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Five-Year Study of Tacrolimus as Secondary Intervention Versus Continuation of Cyclosporine in Renal Transplant Patients at Risk for Chronic Renal Allograft Failure

D. Rush, B. Kiberd, S. Paraskevas, 2008, Transplantation.

Hypertension-based clinical risk strategies for detecting microalbuminuria in diabetes.

B. Singh, B. Kiberd, D. Kamalakannan, 2005, QJM : monthly journal of the Association of Physicians.

ESTIMATING THE BENEFITS OF SOLITARY PANCREAS TRANSPLANTATION IN NONUREMIC PATIENTS WITH TYPE 1 DIABETES MELLITUS: A THEORETICAL ANALYSIS

T. Larson, B. Kiberd, 2000, Transplantation.

Canadian Society of Transplantation and Canadian Society of Nephrology Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors

S. Klarenbach, G. Knoll, B. Kiberd, 2020, Canadian journal of kidney health and disease.

Screening for proteinuria in kidney transplant recipients.

B. Kiberd, R. Panek, Tarek I. Lawen, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Diabetes mellitus in transplantation: 2002 consensus guidelines.

R. Loertscher, B. Kiberd, S. Kim, 2003, Transplantation proceedings.

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation

Roger B. Davis, B. Kiberd, A. Vinson, 2018, Transplantation direct.

Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population.

B. Kiberd, T. Keough-Ryan, J. Lawen, 2005, Transplantation proceedings.

The functional and structural changes of the glomerulus throughout the course of murine lupus nephritis.

B. Kiberd, 1992, Journal of the American Society of Nephrology : JASN.

Outcome of the acute glomerular injury in proliferative lupus nephritis.

B. Kiberd, R. Hoppe, B. Myers, 1989, The Journal of clinical investigation.

Treatment of lupus nephritis with total lymphoid irradiation. Observations during a 12-79-month followup.

B. Kiberd, R. Hoppe, B. Myers, 1988, Arthritis and rheumatism.

Lupus nephritis after total lymphoid irradiation: persistent improvement and reduction of steroid therapy.

B. Kiberd, R. Hoppe, B. Myers, 1987, Annals of internal medicine.

Can the outcome of older donor kidneys in transplantation be predicted? An analysis of existing scoring systems

B. Kiberd, D. Singh, J. Lawen, 2004, Clinical transplantation.

Murine lupus nephritis. A structure-function study.

B. Kiberd, 1991, Laboratory investigation; a journal of technical methods and pathology.

Post‐transplant erythrocytosis: a disappearing phenomenon?

B. Kiberd, 2009, Clinical transplantation.

Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report

R. Hasz, A. Caliendo, S. Kleinman, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Effect of Routine Magnesium Supplementation on Blood Pressure and Blood Lipids in Cyclosporine-Treated Renal Allograft Recipients

B. Kiberd, 1993 .

Targeting cardiovascular risk in renal transplantation.

B. Kiberd, K. West, 2001, Transplantation proceedings.

Use of magnetic resonance angiography to treat ischemic nephropathy.

B. Kiberd, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Simultaneous Liver Kidney Transplantation: A Medical Decision Analysis

B. Kiberd, K. Peltekian, C. Skedgel, 2011, Transplantation.

Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study.

B. Kiberd, K. West, Vivian Charles McAlister, 2001, Journal of the American Society of Nephrology : JASN.

Equitable allocation versus best outcome: competing economic and ethical strategies in renal transplantation.

B. Kiberd, 1992, Annals.

Should hepatitis C-infected kidneys be transplanted in the United States?

B. Kiberd, 1994, Transplantation.

Cost‐Effectiveness of Organ Donation: Evaluating Investment into Donor Action and Other Donor Initiatives

Paul Keown, B. Kiberd, J. Whiting, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Access to kidney transplantation: outcomes of the non-referred

S. Soroka, B. Kiberd, K. Tennankore, 2012, Transplantation research.

The Role of Donor Sex in Females Undergoing Repeat Kidney Transplant: Does Prior Donor Sex Matter?

B. Kiberd, George Worthen, A. Vinson, 2022, Transplantation direct.

Barriers to access before initiation of hemodialysis: A single‐center review

S. Soroka, B. Kiberd, V. Bhan, 2007, Hemodialysis international. International Symposium on Home Hemodialysis.

Screening to Prevent Polyoma Virus Nephropathy: A Medical Decision Analysis

B. Kiberd, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Established murine lupus nephritis does not respond to exogenous interleukin-1 receptor antagonist; a role for the endogenous molecule?

B. Kiberd, A. Stadnyk, 1995, Immunopharmacology.

Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?

B. Kiberd, K. Jindal, 1999, Mayo Clinic proceedings.

Optimizing Ambulance Transport of Hemodialysis Patients to the Emergency Department: A Cohort Study

B. Kiberd, A. Vinson, K. Tennankore, 2019, Canadian journal of kidney health and disease.

Burden of Emergency Medical Services Usage by Dialysis Patients

B. Kiberd, A. Vinson, K. Tennankore, 2018, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

A contemporary description of patients’ estimated blood losses from diagnostic phlebotomy in a census of hospital episodes from a Canadian tertiary care center

A. Levy, S. Doucette, B. Kiberd, 2019, Transfusion.

Therapeutic monitoring of cyclosporine in kidney transplantation: the Halifax experience.

B. Kiberd, P. Belitsky, J. Lawen, 2004, Transplantation proceedings.

Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study.

B. Kiberd, C. Clase, T. Keough-Ryan, 2001, Transplantation proceedings.

Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.

B. Kiberd, Vivian Charles McAlister, A. Macdonald, 2001, Transplantation proceedings.

Lifetime risks of kidney donation: a medical decision analysis

B. Kiberd, K. Tennankore, 2017, BMJ Open.

Kidney donation and risk of ESRD.

B. Kiberd, K. Tennankore, 2014, JAMA.

Contraindications to kidney transplantation: uneven grounds?

B. Kiberd, K. Tennankore, M. AlBugami, 2015, Transplantation research.

The Association of Pre-Transplant C-Peptide Level with the Development of Post-Transplant Diabetes: A Cohort Study

B. Kiberd, A. Vinson, L. Gunaratnam, 2022, Kidney360.

Interleukin-6 receptor blockage ameliorates murine lupus nephritis.

B. Kiberd, 1993, Journal of the American Society of Nephrology.

BK virus nephropathy in a heart transplant recipient: case report and review of the literature

B. Kiberd, P. Acott, L. Geldenhuys, 2006, Transplant infectious disease : an official journal of the Transplantation Society.

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

Ethan M Balk, Gowri Raman, Amy Earley, 2010, Kidney international.

Kidney transplant survival in pediatric and young adults

B. Kiberd, P. Acott, J. Kiberd, 2011, BMC nephrology.

Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder

R. Mustafa, S. Soroka, M. Bevilacqua, 2020, Canadian journal of kidney health and disease.

Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation

D. Rush, G. Knoll, B. Kiberd, 2005, Canadian Medical Association Journal.

Panic in the Pandemic: When Should Kidney Transplant Programs Close?

B. Kiberd, A. Vinson, K. Tennankore, 2021, Kidney international reports.

Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling

B. Kiberd, C. Clase, K. West, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients.

B. Kiberd, K. West, K. Kamal, 2003, Transplantation proceedings.

IS ROUTINE URETERIC STENTING NEEDED IN KIDNEY TRANSPLANTATION? A RANDOMIZED TRIAL

B. Kiberd, C. Clase, Vivian Charles McAlister, 2000, Transplantation.

Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation

B. Kiberd, K. Jindal, 1995, BMJ.

The morbidity of prolonged wound drainage after kidney transplantation.

B. Kiberd, C. Clase, Vivian Charles McAlister, 1999, The Journal of urology.

Disparities in Access to Preemptive Repeat Kidney Transplant: Still Missing the Mark?

B. Kiberd, A. Vinson, K. West, 2021, Kidney360.

Donor-Recipient Weight and Sex Mismatch and the Risk of Graft Loss in Renal Transplantation.

B. Kiberd, K. Tennankore, A. Odutayo, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Impact of acute rejection on long-term graft survival in HLA-identical living-related kidney transplants.

B. Kiberd, J. Lawen, A. Macdonald, 2001, Transplantation proceedings.

The windows of opportunity.

B. Kiberd, W. Lim, 2022, Kidney international.

Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants

B. Kiberd, Vivian Charles McAlister, P. Belitsky, 2000, Clinical transplantation.

Predictors and Complications of Post Kidney Transplant Leukopenia

Alyne G. Teixeira, B. Kiberd, A. Vinson, 2021, Progress in transplantation.

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency.

A. Levin, M. Tonelli, S. Pandeya, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Targeting the Opioid Pathway for Uremic Pruritus

J. Hayden, B. Kiberd, K. Tennankore, 2016, Canadian journal of kidney health and disease.

Kidney transplantation, the Halifax experience.

B. Kiberd, K. West, I. Sketris, 1996, Clinical transplants.

De Novo Donor‐Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Posttransplantation: A Medical Decision Analysis

B. Kiberd, K. Tennankore, A. Miller, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CONVERSION TO RAPAMYCIN IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS: REPORT OF AN INITIAL EXPERIENCE1

B. Kiberd, Vivian Charles McAlister, J. Dominguez, 2000, Transplantation.

Optimal Sequencing of Deceased Donor and Live Donor Kidney Transplant Among Pediatric Patients With Kidney Failure

B. Kiberd, A. Vinson, K. Tennankore, 2022, JAMA network open.

Frailty in end-stage renal disease: comparing patient, caregiver, and clinician perspectives

B. Kiberd, K. Tennankore, P. Moorhouse, 2017, BMC Nephrology.

Frailty and mortality in dialysis: evaluation of a clinical frailty scale.

S. Soroka, B. Kiberd, K. Tennankore, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Access to the Kidney Transplant Wait List

B. Kiberd, J. Boudreault, R. Panek, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Comorbidity burden at dialysis initiation and mortality: A cohort study

B. Hemmelgarn, S. Soroka, B. Kiberd, 2015, Canadian journal of kidney health and disease.

Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study

S. Soroka, B. Kiberd, K. West, 2011, BMC nephrology.

Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III.

A. Garg, R. Haynes, R. Haynes, 2003, Kidney international.

Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency

F. Sacks, M. Tonelli, G. Curhan, 2003, Annals of Internal Medicine.

Screening for Prostate, Breast and Colorectal Cancer in Renal Transplant Recipients

B. Kiberd, C. Clase, T. Keough-Ryan, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine.

B. Kiberd, K. West, Vivian Charles McAlister, 1997, Transplantation proceedings.

Effect of atrial natriuretic peptide on vasa recta blood flow in the rat.

T. Larson, B. Kiberd, C. Robertson, 1987, The American journal of physiology.

Malignancies: pre and post transplantation strategies.

B. Kiberd, M. AlBugami, 2014, Transplantation reviews.

Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study

N. Tangri, S. Doucette, B. Kiberd, 2020, Canadian journal of kidney health and disease.

NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES

B. Kasiske, D. Wheeler, P. Marchetti, 2003 .

RENAL TRANSPLANTATION WITHOUT STEROIDS ‐ ONE YEAR RESULTS OF A MULTICENTRE CANADIAN PILOT STUDY.: Abstract# 86

B. Kiberd, P. Halloran, E. Cole, 2000 .

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.

B. Kiberd, P. Halloran, D. Landsberg, 2001, Transplantation.

Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?

B. Kiberd, P. Belitsky, J. Lawen, 2000, The Journal of urology.

Hepatitis C virus–infected kidney waitlist patients: Treat now or treat later?

B. Kiberd, A. Vinson, K. Tennankore, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Predicting 5-year risk of kidney transplant failure: a prediction instrument using data available at 1 year posttransplantation.

A. Cherukuri, B. Kiberd, C. Ferro, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

An Economic Model of 2-Hour Post-Dose Ciclosporin Monitoring in Renal Transplantation

B. Kiberd, C. Marra, R. Balshaw, 2012, PharmacoEconomics.

Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics

M. Pescovitz, D. Conti, B. Kiberd, 2000 .

Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.

M. Pescovitz, D. Conti, B. Kiberd, 1999, Clinical transplantation.

Prevalence and prognostic factors for erectile dysfunction in renal transplant recipients.

B. Kiberd, J. Lawen, J. A. Wong, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Prevalence and prognostic factors for erectile dysfunction in renal transplant recipients ORGINAL RESEARCH

B. Kiberd, J. Lawen, J. A. Wong, 2007 .

Early recurrence of primary focal segmental glomerulosclerosis in an older cadaveric renal allograft recipient resistant to plasmapheresis.

B. Kiberd, D. Singh, P. Belitsky, 2006, Urology.

Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.

M. Pescovitz, K. Budde, R. Walker, 2011, Transplantation reviews.

Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation.

B. Kiberd, K. Tennankore, S. Kim, 2016, Kidney international.

Blood transfusion in deceased donor kidney transplantation

B. Kiberd, K. Marzouk, J. Lawen, 2013, Transplantation research.

A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels.

B. Kiberd, K. West, Vivian Charles McAlister, 2000, Transplantation proceedings.

New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

C., B. Kasiske, Ľ., 2003, Transplantation.

Comparing the Net Benefits of Adult Deceased Donor Kidney Transplantation for a Patient on the Preemptive Waiting List vs a Patient Receiving Dialysis

B. Kiberd, A. Vinson, K. Tennankore, 2022, JAMA network open.

Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III

A. Garg, R. Haynes, W. Clark, 2002 .

The chronic kidney disease epidemic: stepping back and looking forward.

B. Kiberd, 2006, Journal of the American Society of Nephrology : JASN.

Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation

D. Rush, G. Knoll, B. Kiberd, 2005, Canadian Medical Association Journal.

New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

Bertram L Kasiske, Domingo Hernández, Piero Marchetti, 2003, Transplantation.

Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency.

A. Levin, M. Tonelli, S. Pandeya, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Slowing the progression of chronic renal insufficiency.

A. Levin, M. Tonelli, S. Pandeya, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Cyclosporine-induced renal dysfunction in human renal allograft recipients.

B. Kiberd, 1989, Transplantation.

Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period.

B. Kiberd, S. Tett, J. Lawen, 2005, Transplantation proceedings.

The Role of Proton Pump Inhibitors on Early Mycophenolic Acid Exposure in Kidney Transplantation: Evidence From the CLEAR Study

B. Kiberd, P. Keown, S. Gourishankar, 2011, Therapeutic drug monitoring.

Cardiovascular risk reduction in renal transplantation. Strategies for success.

B. Kiberd, 2002, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Cardiovascular Disease Reduction in the Outpatient Kidney Transplant Clinic

B. Kiberd, T. Keough-Ryan, R. Panek, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.

B. Kiberd, C. Cardella, D. Landsberg, 2010, Clinical journal of the American Society of Nephrology : CJASN.

A Survey of Increased Infectious Risk Donor Utilization in Canadian Transplant Programs

Deepali Kumar, A. Humar, B. Kiberd, 2016, Transplantation.

Classifying kidney problems: can we avoid framing risks as diseases?

Amit X Garg, A. Garg, B. Kiberd, 2004, BMJ : British Medical Journal.

Screening for BK viremia.

B. Kiberd, M. AlBugami, 2013, Transplantation.

Challenges in the Management of the Kidney Allograft: From Decline to Failure: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

B. Kasiske, M. Jadoul, W. Winkelmayer, 2023, Kidney international.

Quality of prereferral care in patients with chronic renal insufficiency.

D. Hirsch, B. Kiberd, K. Jindal, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Economic Evaluation of Screening for Polyomavirus Infection in Kidney Transplant Recipients: A Cost-Utility Analysis

J. Craig, D. Axelrod, B. Kiberd, 2022, Transplantation direct.

Incidence, etiology, and significance of acute kidney injury in the early post‐kidney transplant period

B. Kiberd, K. Tennankore, R. Panek, 2016, Clinical transplantation.

Prolonged Cold Ischemia Time Offsets the Benefit of Human Leukocyte Antigen Matching in Deceased Donor Kidney Transplant.

B. Kiberd, A. Vinson, K. Tennankore, 2020, Transplantation proceedings.

Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?

B. Kiberd, K. Peltekian, K. Thompson, 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited.

B. Kiberd, R. Panek, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Nephrology consults increase.

S. Soroka, B. Kiberd, 2010, Kidney international.

Strategies to reduce clinical inertia in hypertensive kidney transplant recipients

B. Kiberd, J. Kiberd, Romauld Panek, 2007, BMC nephrology.

Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantation.

B. Kiberd, P. Belitsky, J. Lawen, 2003, Transplantation proceedings.

MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.

B. Kiberd, B. Nashan, P. Belitsky, 2006, Transplantation proceedings.

The differential impact of size mismatch in live versus deceased donor kidney transplant

B. Kiberd, A. Vinson, K. Tennankore, 2021, Clinical transplantation.

Donor-Recipient Matching in Kidney Transplant: We're Not There Yet.

B. Kiberd, A. Vinson, K. Tennankore, 2021, Transplantation proceedings.

Basiliximab lowers the cyclosporine therapeutic threshold in the early post‐kidney transplant period

B. Kiberd, J. Lawen, A. Fraser, 2005, Clinical transplantation.

Colorectal cancer screening in kidney disease patients: working backwards.

B. Kiberd, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Routine treatment of insulin-dependent diabetic patients with ACE inhibitors to prevent renal failure: an economic evaluation.

B. Kiberd, K. Jindal, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A patient centered approach to the treatment of renal vascular disease to prevent end stage renal failure.

B. Kiberd, 1997, Geriatric nephrology and urology.

Chronic Diarrhea in Kidney Transplant Recipients.: Abstract# D2462

B. Kiberd, 2014 .

Screening for West Nile Virus in Organ Transplantation: A Medical Decision Analysis

B. Kiberd, Bryce A Kiberd, Kevin Forward, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Transplanting Hepatitis C VirusInfected or Uninfected Kidneys Into Hepatitis C VirusInfected Recipients

B. Kiberd, A. Vinson, K. Tennankore, 2018, Annals of Internal Medicine.

The Use of Donation After Cardiac Death Organs for Simultaneous Liver-Kidney Transplant: To DCD or Not to DCD?

B. Kiberd, A. Vinson, K. Tennankore, 2019, Transplantation.

Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.

M. Pescovitz, K. Budde, R. Walker, 2011 .

Multiview Clustering to Identify Novel Kidney Donor Phenotypes for Assessing Graft Survival in Older Transplant Recipients

B. Kiberd, George Worthen, A. Vinson, 2023, Kidney360.

Rationale, design and statistical analysis of a prospective randomized trial comparing initially intensified vs standard dose regimens of enteric-coated mycophenolate sodium in De novo renal transplant patients

K. Budde, W. Arns, R. Walker, 2007 .

Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation

B. Kiberd, C. Staatz, S. Tett, 2005, European Journal of Clinical Pharmacology.

The fate of the failed renal transplant.

B. Kiberd, P. Belitsky, 1995, Transplantation.

B Cells and Kidney Transplantation: Beyond Antibodies

B. Kasiske, P. Fauchald, A. Matas, 2014 .

A Location-Based Objective Assessment of Physical Activity and Sedentary Behavior in Ambulatory Hemodialysis Patients

B. Kiberd, A. Vinson, K. Tennankore, 2019, Canadian journal of kidney health and disease.

Journal Pre-proof Challenges in the Management of the Kidney Allograft: From Decline to Failure: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

B. Tönshoff, B. Kiberd, A. Loupy, 2022 .

High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation

W. McMaster, F. Claas, A. Humar, 2021, Communications Biology.

Screening for chronic kidney disease

I. D. de Boer, B. Kiberd, U. Patel, 2010, BMJ : British Medical Journal.

Strategies to reduce clinical inertia in hypertensive kidney transplant recipients

B. Kiberd, J. Kiberd, Romauld Panek, 1997, BMC nephrology.

Polymorphisms of Multidrug Resistance Gene (MDR1) and Cyclosporine Absorption in De Novo Renal Transplant Patients

B. Kiberd, B. Nashan, P. Belitsky, 2007, Transplantation.

Cost‐Effectiveness of Routine Nucleic Acid Testing in Organ Donors

B. Kiberd, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.

B. Kiberd, J. Trofe‐Clark, H. Tedesco Silva, 2024, Transplantation.

Incidence, etiology, and significance of acute kidney injury in the early post‐kidney transplant period

B. Kiberd, K. Tennankore, R. Panek, 2016, Clinical transplantation.